Shifting business models need transformational leadership.
Life sciences contribute to improve health and quality of life of the population and ensure economic prosperity. The Swedish life science sector is defined by world-class research and research infrastructure, a health care system of high international standard, competitive industry, and world-leading innovation.
Swedish pharma and medtech companies are situated in a fast-moving globalized marked with increasing mobility of individuals, where the labour market and educational institutions are becoming more and more international, and competition is intensifying for people with cutting-edge expertise. During the recent years, the Life Sciences sector has faced strong levels of M&A activities, increasing the focus on smooth merger processes and solid corporate governance structures.
Amrop Sweden has solid experience from Leadership Advisory activities, Board Evaluations and C-suite placements for both public and private companies within the Pharma, Medtech and Biotech sector. Due to the global nature of the industry, our consultants work seamlessly across our global partnership to deliver outstanding consisting value on each assignment making sure that we bring the right expertise to the table.
We want to hear about your context and specific needs. Reach out to our industry experts to set up a meeting.
